Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Journal of the National Cancer Institute
Observational study suggests hormone therapy safe for postmenopausal BRCA mutation carriers
October 9th, 2008
The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study published online September 23 in the Journal of the National Cancer Institute. Women who carry a mutation in the BRCA1 gene may opt to have their ovaries removed to lower their risk of developing breast cancer. The surgery, however, induces menopause, and thus some women opt to take hormone therapy to reduce its symptoms. The impact of hormone therapy on the risk of breast cancer in these women is not known. To find out, Steven Narod, M.D., of the University of Toronto and colleagues...
Source: Women's Health Weekly (2008-10-09)
|
